PortfoliosLab logo

Bone Biologics Corporation (BBLG)

Equity · Currency in USD · Last updated Dec 2, 2022

Company Info

ISINUS0980703039
CUSIP098070303
SectorHealthcare
IndustryMedical Devices

Trading Data

Previous Close$0.28
Year Range$0.27 - $5.39
EMA (50)$0.55
EMA (200)$1.53
Average Volume$254.54K
Market Capitalization$4.29M

BBLGShare Price Chart


Loading data...

BBLGPerformance

The chart shows the growth of $10,000 invested in Bone Biologics Corporation in Apr 2016 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $27 for a total return of roughly -99.73%. All prices are adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
-81.76%
-1.10%
BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)

BBLGCompare to other instruments

Search for stocks, ETFs, and funds to compare with BBLG

BBLGReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-37.76%5.28%
6M-81.93%-0.60%
YTD-92.04%-14.47%
1Y-92.28%-10.74%
5Y-98.85%-1.84%
10Y-97.30%-1.60%

BBLGMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-39.20%-14.95%52.75%-21.58%-27.29%-11.67%-8.57%4.69%-21.64%-57.14%-33.33%-6.63%
20210.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-73.33%-27.40%-3.03%
20200.00%0.00%0.00%0.00%0.00%0.00%0.00%-25.00%0.00%-16.67%110.00%42.86%
20190.00%0.00%-61.54%0.00%0.00%0.00%0.00%0.00%-15.00%0.00%0.00%-52.94%
2018-55.56%13.10%164.37%-33.11%12.50%-11.11%30.00%0.00%0.00%0.00%0.00%0.00%
2017-50.00%0.00%-5.00%-23.68%20.69%127.26%44.58%-4.35%-4.55%-11.43%7.31%-54.91%
20169.76%11.11%0.00%-2.00%-59.18%44.50%24.57%25.00%-11.11%

BBLGSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Bone Biologics Corporation Sharpe ratio is -0.71. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.20JulyAugustSeptemberOctoberNovemberDecember
-0.71
-0.40
BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)

BBLGDividend History


Bone Biologics Corporation doesn't pay dividends

BBLGDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-99.81%
-15.01%
BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)

BBLGWorst Drawdowns

The table below shows the maximum drawdowns of the Bone Biologics Corporation. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Bone Biologics Corporation is 99.82%, recorded on Nov 22, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.82%Aug 17, 2017356Nov 22, 2022
-78.45%Aug 18, 201618Jan 3, 201717Jul 18, 201735
-2%Jul 22, 20161Jul 22, 20161Aug 8, 20162

BBLGVolatility Chart

Current Bone Biologics Corporation volatility is 93.23%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%250.00%JulyAugustSeptemberOctoberNovemberDecember
93.23%
20.33%
BBLG (Bone Biologics Corporation)
Benchmark (^GSPC)